Attralus
PrivateLast Round
Series B
Extension
Feb 6, 2024
Est. Valuation
$426M
Total Funding Raised
$197M
Company Overview
Attralus is a biotechnology company that develops immunotherapies and imaging diagnostic platforms for the treatment of systemic amyloid diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attralus Comparables
Compare Attralus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prothena Corporation plc | 78% | |
| Paradox Immunotherapeutics | 77% | |
| Immutrin | 74% | |
Attralus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 6, 2024 | ||||
| Series B | Sep 8, 2021 | ||||
| Series A | Sep 14, 2020 |
Key People
Founding team and executive leadership
Attralus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B |
| Surveyor Capital | Series B Extension, Series B |
| Janus Henderson Group | Series B |
| Logos Capital | Series B Extension, Series B |
| Citadel | Series B Extension, Series B |
| venBio | Series B Extension, Series B, Series A |
| Samsara BioCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2024
$56M round led by Alpha Wave Global
- Sep 8, 2021
$116M round led by Logos Capital.
Attralus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Attralus's valuation, stock price, and market status.